{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:17:33Z","timestamp":1793078253110,"version":"4.5.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.1095\/biolreprod.115.136283","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T05:30:40Z","timestamp":1460007040000},"source":"Crossref","is-referenced-by-count":35,"title":["Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep1"],"prefix":"10.1093","volume":"94","author":[{"given":"Chunxia","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo C.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muraly","family":"Puttabyatappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170225013311_CIT0001","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","year":"2014","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170225013311_CIT0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170225013311_CIT0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170225013311_CIT0004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","year":"2015","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20170225013311_CIT0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2013.1236","article-title":"NIH panel: name change, new priorities advised for polycystic ovary syndrome","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170225013311_CIT0006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0007","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","year":"2012","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20170225013311_CIT0008","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0009","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000341682","article-title":"Genetics of polycystic ovary syndrome","volume":"40","year":"2013","journal-title":"Front Horm Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0011","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","year":"2010","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170225013311_CIT0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","article-title":"Nonhuman primate models of polycystic ovary syndrome","volume":"373","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t20170225013311_CIT0013","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0034-1371090","article-title":"Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions","volume":"32","year":"2014","journal-title":"Semin Reprod Med"},{"key":"key\n\t\t\t\t20170225013311_CIT0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype","volume":"373","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t20170225013311_CIT0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.steroids.2013.05.004","article-title":"Animal models of the polycystic ovary syndrome phenotype","volume":"78","year":"2013","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20170225013311_CIT0016","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1210\/en.2010-0666","article-title":"Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues","volume":"151","year":"2010","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0017","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170225013311_CIT0018","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/dem090","article-title":"Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170225013311_CIT0019","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1210\/en.2014-2006","article-title":"Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep","volume":"156","year":"2015","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/en.2003-0478","article-title":"Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep","volume":"145","year":"2004","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0021","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1210\/en.2007-1382","article-title":"Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep","volume":"149","year":"2008","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0022","first-page":"402","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170225013311_CIT0023","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00404-009-1305-8","article-title":"A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate","volume":"281","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20170225013311_CIT0024","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1210\/en.2010-0124","article-title":"Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep","volume":"151","year":"2010","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0025","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1210\/en.2015-1235","article-title":"Abi Salloum B, Moeller J, Beckett E, Sreedharan R. Developmental programming: prenatal and postnatal androgen antagonist and insulin sensitizer interventions prevent advancement of puberty and improve LH surge dynamics in prenatal testosterone-treated sheep","volume":"156","year":"2015","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0026","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1210\/en.2015-1565","article-title":"Developmental programming: impact of gestational steroid and metabolic milieus on adiposity and insulin sensitivity in prenatal testosterone-treated female sheep","volume":"157","year":"2016","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0027","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/joe.0.0890229","article-title":"Importance of variations in behavioural and feedback actions of oestradiol to the control of seasonal breeding in the ewe","volume":"89","year":"1981","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20170225013311_CIT0028","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.theriogenology.2006.08.010","article-title":"Developmental programming in sheep: administration of testosterone during 60\u201390 days of pregnancy reduces breeding success and pregnancy outcome","volume":"67","year":"2007","journal-title":"Theriogenology"},{"key":"key\n\t\t\t\t20170225013311_CIT0029","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/en.2002-220965","article-title":"Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep","volume":"144","year":"2003","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1113\/jphysiol.2005.103929","article-title":"Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep","volume":"572","year":"2006","journal-title":"J Physiol"},{"key":"key\n\t\t\t\t20170225013311_CIT0031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/en.2009-1015","article-title":"Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females","volume":"151","year":"2010","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0032","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.1074\/jbc.M113.460212","article-title":"Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity","volume":"288","year":"2013","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170225013311_CIT0033","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2337\/diabetes.51.8.2412","article-title":"Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPAR\u03b3 agonists","volume":"51","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0034","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/MCB.01405-07","article-title":"Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity","volume":"28","year":"2008","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170225013311_CIT0035","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.2337\/diabetes.53.12.3048","article-title":"Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes","volume":"53","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nutr.19.1.379","article-title":"Regulation of glucose production by the liver","volume":"19","year":"1999","journal-title":"Ann Rev Nutr"},{"key":"key\n\t\t\t\t20170225013311_CIT0037","first-page":"3895","article-title":"Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival","volume":"30","year":"2010","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0038","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1158\/0008-5472.CAN-05-4472","article-title":"Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins","volume":"66","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1757-2215-5-38","article-title":"The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)","volume":"5","year":"2012","journal-title":"J Ovarian Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0040","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)","volume":"270","year":"1995","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170225013311_CIT0041","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","article-title":"Thiazolidinediones in the treatment of insulin resistance and type II diabetes","volume":"45","year":"1996","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0042","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/meta.2001.27202","article-title":"Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats","volume":"50","year":"2001","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20170225013311_CIT0043","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/db06-1065","article-title":"Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance","volume":"56","year":"2007","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0044","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diabetes.52.6.1311","article-title":"Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP\/F-1 fatless mice","volume":"52","year":"2003","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4161\/cbt.5.8.2887","article-title":"PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404","volume":"5","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t20170225013311_CIT0046","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1389450110607011435","article-title":"Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes","volume":"7","year":"2006","journal-title":"Current Drug Targets"},{"key":"key\n\t\t\t\t20170225013311_CIT0047","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1128\/MCB.00763-08","article-title":"Tissue-specific role of glycogen synthase kinase 3\u03b2 in glucose homeostasis and insulin action","volume":"28","year":"2008","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170225013311_CIT0048","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2007.03.006","article-title":"The GLUT4 glucose transporter","volume":"5","year":"2007","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0049","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2337\/diab.45.1.28","article-title":"Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle","volume":"45","year":"1996","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0050","first-page":"E593","article-title":"Glucose transporter protein content and glucose transport capacity in rat skeletal muscles","volume":"259","year":"1990","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170225013311_CIT0051","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/MCB.22.7.2099-2110.2002","article-title":"Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway","volume":"22","year":"2002","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170225013311_CIT0052","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/jcs.091991","article-title":"Inhibition of GSK3 by Wnt signalling\u2013two contrasting models","volume":"124","year":"2011","journal-title":"J Cell Sci"},{"key":"key\n\t\t\t\t20170225013311_CIT0053","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/diabetes.54.5.1459","article-title":"Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study","volume":"54","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0054","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1158\/0008-5472.CAN-06-1895","article-title":"Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain","volume":"66","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0055","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","article-title":"Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer","volume":"11","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170225013311_CIT0056","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women","volume":"192","year":"2007","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20170225013311_CIT0057","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/bj20031207","article-title":"an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo","volume":"377","year":"2004","journal-title":"Biochem. J"},{"key":"key\n\t\t\t\t20170225013311_CIT0058","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1152\/ajpendo.00107.2005","article-title":"Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone","volume":"289","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0059","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1210\/en.2012-2145","article-title":"Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep","volume":"154","year":"2013","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170225013311_CIT0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1071\/AN14434","article-title":"Ruminant glycogen metabolism","volume":"54","year":"2014","journal-title":"Anim Prod Sci"},{"key":"key\n\t\t\t\t20170225013311_CIT0061","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0062","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/db07-0706","article-title":"Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170225013311_CIT0063","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcte.2015.06.002","article-title":"Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome","volume":"2","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"key\n\t\t\t\t20170225013311_CIT0064","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2008-1492","article-title":"Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/humrep\/17.3.771","article-title":"Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study","volume":"17","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170225013311_CIT0066","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170225013311_CIT0067","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"key\n\t\t\t\t20170225013311_CIT0068","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fertnstert.2011.11.029","article-title":"Does PCOS have developmental origins?","volume":"97","year":"2012","journal-title":"Fertil Steril"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/94\/5\/113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:48:28Z","timestamp":1655448508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-lookup\/doi\/10.1095\/biolreprod.115.136283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1095\/biolreprod.115.136283","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}